Posts

Nebraska scientists closing in on long-lasting swine fl...

A successful long-term experiment with live hogs indicates Nebraska scientists m...

To prevent future pandemics, leave bats alone

A new paper in the journal The Lancet Planetary Health makes the case that pande...

Investments advance brain research, name MRI for longti...

The Laurie and Todd Platt BrainHealth Project MRI Scanner will help researchers ...

Two brain mechanisms for picking speech out of a crowd

Researchers led by Dr. Nima Mesgarani at Columbia University, US, report that th...

Does multimorbidity impact chronic disease treatment?

Treatment efficacy for a broad range of chronic diseases does not differ dependi...

Order in chaos: Atmosphere’s Antarctic oscillation has ...

HOUSTON – (June 6, 2023) – Climate scientists at Rice University have discovered...

Researchers dig deep to unveil causes of decline for No...

The American Kestrel, a colorful and charismatic falcon, has kept researchers sc...

Revolutionizing optical control with topological edge s...

Nanophotonics and topology have gained significant interest due to the unique pr...

Knowledge coproduction: Working together to solve a com...

A new publication from a team of scientists at USGS, Point Blue Conservation Sci...

Kid EDV by ImmunityBio for Pediatric Diffuse Intrinsic ...

Kid EDV is under clinical development by ImmunityBio and currently in Phase I fo...

OCX-063 by OccuRx for Proliferative Vitreoretinopathy (...

OCX-063 is under clinical development by OccuRx and currently in Phase I for Pro...

Izokibep by Acelyrin for Panuveitis: Likelihood of Appr...

Izokibep is under clinical development by Acelyrin and currently in Phase II for...

Pralsetinib by F. Hoffmann-La Roche for Pancreatic Canc...

Pralsetinib is under clinical development by F. Hoffmann-La Roche and currently ...

Rezvilutamide by Jiangsu Hengrui Medicine for Prostate ...

Rezvilutamide is under clinical development by Jiangsu Hengrui Medicine and curr...

Selvita and the University of Oxford join forces to tac...

The collaboration centres on developing protein degraders that could provide an ...

ASCO 2023: Summit Therapeutics plans to rise with bispe...

Recent trial data with ivonescimab indicates the treatment could be a much-neede...